Knowing stock market today at a glance

Ocular Therapeutix Soars 14.19% on Q4 Earnings, AMD Progress

Mover TrackerTuesday, Apr 1, 2025 4:52 am ET

1min read

Ocular Therapeutix's stock surged 14.19% in pre-market trading on April 1, 2025, marking a significant rise for the biopharmaceutical company.

Ocular Therapeutix recently reported its Q4 and full-year 2024 results, showcasing notable advancements in its AXPAXLI registrational program for wet age-related macular degeneration (AMD). This progress has been a key driver for investor optimism, as the company continues to make strides in its retinal therapies.

Additionally, the company's insider trading activities have also garnered attention. Pravin Dugel, an insider, sold 21,475 shares of the company's stock on February 24th, which could be seen as a strategic move to manage personal holdings rather than a negative indicator for the company's prospects.

Ocular Therapeutix is set to participate in two investor conferences, further highlighting its commitment to engaging with the investment community and showcasing its innovative retinal therapies. The company's upcoming presentations at the Angiogenesis, Exudation, and Degeneration 2025 Virtual Meeting are expected to provide more insights into its pipeline and strategic direction.

Comments

Add a public comment...

Post

Antinetdotcom

04/01

14% surge? Looks like $OCUL is on fire! 🚀

OkBag6609

@Antinetdotcom Big gains, right?

Throwaway420_69____

@Antinetdotcom Any thoughts on their AMD progress?

maximalsimplicity

Anyone else think Ocular's pipeline is a hidden gem? Time to dig deeper.

Pin-Last

@maximalsimplicity What do you think about their AMD progress?

Senyorty12

Holding $OCUL long-term. Retinal therapies have massive potential. Diversifying my portfolio next.

OwlGlad6122

@Senyorty12 How long you been holding $OCUL? Curious if you got a timeline for when you'd cash out.

skilliard7

OCULar Therapeutix's 14% pop is no joke, but keep an eye on that pipeline for real growth. 🚀

Mr_Biddz

Ocular's pipeline is 🔥, but watch insider moves.

cfeltus23

@Mr_Biddz What do you think about Dugel's move?

NRG1788

Ocular's engagement with investors shows confidence. They're not hiding anything. Transparency matters.

Lets_make_this_money

@NRG1788 True, Ocular's being transparent. Good move.

JobuJabroni

Wet AMD treatment is a goldmine if Ocular plays it right. $OCUL looking promising.

FlowLongjumping8948

@JobuJabroni What's your price target?

Haardikkk

Ocular's got juice with their AMD moves. Anyone riding this rocket to the moon? 🚀

MasterDeath

Pravin Dugel selling shares? Maybe he's cashing out fat stacks, but it's not a red flag.

alecjperkins213

14% surge? Insiders must know something. Time to load up or nah?

SomeSortOfBrit

Pravin Dugel knows what he's doing with those shares.

BeefMasters1

Angiogenesis conference could be a game-changer. Ocular might drop major news. Keep eyes peeled.

joe4942

Biopharma space is wild. Ocular's got the spotlight. What's the next big player to watch?

Cannannaca

AMD progress = bullish signal. Holding long-term.

Electrical_Love_3670

@Cannannaca What’s your target price?

Tiger_bomb_241

Gotta research more on AXPAXLI, this could be huge.